UNSPSC 85492146: Bypass coronary artery, three sites from left internal mammary with synthetic substitute, percutaneous endoscopic approach

This classification denotes the group of activities that yields a surgical intervention or procedure to bypass coronary artery, three sites from left internal mammary with synthetic substitute, percutaneous endoscopic approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 02124J9

UNSPSC 85492146 Bypass coronary artery, three sites from left internal mammary with synthetic substitute, percutaneous endoscopic approach is a Commodity code that in practice does not align with state and local government procurement activity. The code describes a specific cardiac surgical procedure; recent state and local opportunities tagged under this code reflect occupational health surveillance, independent medical evaluations for pension disability determinations, pharmacy benefit management, specialty surgical networks, temporary clinical staffing, and emergency medical services for detained youth—none of which involve coronary artery bypass surgery or cardiac interventions as procured goods or services.

State and local issuers across Arizona, California, Washington, and Florida have posted opportunities under this code designation in the past two months, but the mismatch between code intent and actual procurement scope indicates either miscategorization in the source data or systematic misalignment between vendor classification systems and the UNSPSC taxonomy as applied by state and local procurement offices. The Washington State Department of Transportation's request for occupational medical surveillance, the City of Phoenix's independent medical evaluation RFP due October 16, 2026, the City of Long Beach's surgical benefit carve-out program RFP due October 7, and Collier County's pharmacy benefit management RFP represent the recent activity surface, but none involves procurement of the coronary artery bypass procedure itself. No meaningful market signal emerges for this code's nominal scope in state and local contracting.